ESEF — Europäische Jahresabschlüsse (iXBRL) fact · point in time
NOVOZYMES A/S: cash_and_equivalents
One fact, its scope and the complete path back to the official record.
Reported value
275.300M{"amount": 275300000.0, "concept": "ifrs-full:CashAndCashEquivalents"}- Entity
- NOVOZYMES A/S
- Metric
- cash_and_equivalents
- Period
- as of 2025-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:529900T6WNZXD2R3JW38:2026-03-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T22:32:52.133018+02:00
Raw response SHA-256
26b25d5260a1f348b77d6b5c2a54e9db…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.